- Joined
- Apr 11, 2008
- Messages
- 451
- Reaction score
- 90
CDx Diagnostics Helps Physicians Detect Cancer Cells Early
CDx Diagnostics provides AI-enabled tissue analysis and 3D imaging for early detection of precancerous esophageal cells. Learn more: CDx Diagnostics

I’ve argued against GI docs using this testing like candy. Even argued with Dr Odze at that GI path course (2018?) that Harvard and Brigham does (great course by the way). Dr Odze said it’s a wider area of sampling etc etc. Sort of shut me up for a tad.
To date, I’ve never had Endo CDX results differ from my biopsy results, not once in 4 to 5 years. Maybe I’m an anomaly.
I’ve talked to some of the UM Gi group and they thinks it’s a money maker with questionable over utilization. I get it’s use with Barrett’s surveillance.
So I get a recent Endo CDX report back and there is Dr Odze name at the bottom. Hmmmm.......became a Judas I guess.
Anyone else have experiences with this? Care to enlighten the chorus here? Personally, I’m nearly to the point of not caring anymore about path shenanigans.